ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,940 | -40.5% | 13,900 | 0.0% | 0.02% | -33.3% |
| Q2 2023 | $107,447 | +14.0% | 13,900 | 0.0% | 0.03% | +6.5% |
| Q1 2023 | $94,242 | -33.1% | 13,900 | 0.0% | 0.03% | -35.4% |
| Q4 2022 | $140,807 | +2.8% | 13,900 | 0.0% | 0.05% | -9.4% |
| Q3 2022 | $137,000 | -7.4% | 13,900 | 0.0% | 0.05% | -8.6% |
| Q2 2022 | $148,000 | +8.8% | 13,900 | 0.0% | 0.06% | +16.0% |
| Q1 2022 | $136,000 | -31.7% | 13,900 | 0.0% | 0.05% | -30.6% |
| Q4 2021 | $199,000 | – | 13,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |